Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation
暂无分享,去创建一个
C. Van Lint | J. Martinez-Picado | J. Prado | C. Rouzioux | O. Lambotte | A. Sáez-Cirión | G. Pancino | C. Lécuroux | F. Boufassa | A. Venet | V. Avettand-Fenoel | A. David | N. Noel | I. Erkizia | R. Peña | E. Jiménez
[1] M. Lichterfeld,et al. Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth , 2016, PLoS pathogens.
[2] C. Rouzioux,et al. A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control , 2015, AIDS.
[3] F. Pereyra,et al. The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers , 2015, Journal of Virology.
[4] Arsène Burny,et al. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression , 2015, PLoS pathogens.
[5] Richard D Moore,et al. Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection. , 2014, The Journal of infectious diseases.
[6] Daniel I. S. Rosenbloom,et al. Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations. , 2015, The Journal of clinical investigation.
[7] B. Malleret,et al. Long-Term Control of Simian Immunodeficiency Virus (SIV) in Cynomolgus Macaques Not Associated with Efficient SIV-Specific CD8+ T-Cell Responses , 2015, Journal of Virology.
[8] Richard D Moore,et al. Elite Controllers are Hospitalized More Often than Persons with Medically Controlled HIV , 2014 .
[9] Correction for Hill et al., Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1 , 2014, Proceedings of the National Academy of Sciences.
[10] Emily B Hanhauser,et al. Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation , 2014, Annals of Internal Medicine.
[11] F. Pereyra,et al. A cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4(+) T cells from elite controllers. , 2014, Cell host & microbe.
[12] Feng Fu,et al. Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1 , 2014, Proceedings of the National Academy of Sciences.
[13] A. De Maria,et al. Absence of HIV-1 after treatment cessation in an infant. , 2014, The New England journal of medicine.
[14] R. Kaul,et al. Effect of antiretroviral therapy on HIV reservoirs in elite controllers. , 2013, The Journal of infectious diseases.
[15] Sarah B. Laskey,et al. Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.
[16] C. Rouzioux,et al. Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Specific CD8+ T Cell Response in HIV Controllers , 2013, Journal of Virology.
[17] Jeffrey N. Martin,et al. Prospective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers , 2013, PLoS pathogens.
[18] A. Sáez-Cirión,et al. HIV controllers: a genetically determined or inducible phenotype? , 2013, Immunological reviews.
[19] Brigitte Autran,et al. Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study , 2013, PLoS pathogens.
[20] C. Rouzioux,et al. Hiv-1 Control after Transient Antiretroviral Treatment Initiated in Primary Infection: Role of Patient Characteristics and Effect of Therapy , 2012, Antiviral therapy.
[21] J. Gatot,et al. Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients , 2012, AIDS.
[22] F. Pereyra,et al. Elite Controllers with Low to Absent Effector CD8+ T Cell Responses Maintain Highly Functional, Broadly Directed Central Memory Responses , 2012, Journal of Virology.
[23] R. Paredes,et al. In–Depth Characterization of Viral Isolates from Plasma and Cells Compared with Plasma Circulating Quasispecies in Early HIV-1 Infection , 2012, PloS one.
[24] R. Siliciano,et al. Host Factors Dictate Control of Viral Replication in two HIV-1 Controller/Chronic Progressor Transmission Pairs , 2012, Nature Communications.
[25] A. Bergamaschi,et al. Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers. , 2011, Blood.
[26] S. Lewin,et al. HIV cure and eradication: how will we get from the laboratory to effective clinical trials? , 2011, AIDS.
[27] C. Rouzioux,et al. CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory , 2011, PloS one.
[28] E. Rosenberg,et al. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. , 2011, The Journal of clinical investigation.
[29] Jack T Stapleton,et al. The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation , 2010, Science.
[30] Thierry Prazuck,et al. Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection , 2010, AIDS.
[31] C. Mussini,et al. Predictive value of intracellular HIV-1 DNA levels during CD4-guided treatment interruption in HIV+ patients. , 2010, AIDS research and human retroviruses.
[32] A. Sáez-Cirión,et al. Ex vivo T cell–based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses , 2010, Nature Protocols.
[33] R. Siliciano,et al. Control of HIV-1 in Elite Suppressors despite Ongoing Replication and Evolution in Plasma Virus , 2010, Journal of Virology.
[34] M. Carrington,et al. Enhanced Anti-HIV Functional Activity Associated with Gag-Specific CD8 T-Cell Responses , 2010, Journal of Virology.
[35] B. Walker,et al. Replicative Capacity of Human Immunodeficiency Virus Type 1 Transmitted from Mother to Child Is Associated with Pediatric Disease Progression Rate , 2009, Journal of Virology.
[36] Arsène Burny,et al. Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection , 2009, PloS one.
[37] C. Rouzioux,et al. Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses1 , 2009, The Journal of Immunology.
[38] E. Verdin,et al. Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation , 2009, PLoS pathogens.
[39] Amy S. Espeseth,et al. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. , 2009, AIDS research and human retroviruses.
[40] Avettand‐Fènoël Véronique,et al. LTR real‐time PCR for HIV‐1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01) , 2009 .
[41] C. Rouzioux,et al. LTR Real-Time PCR for HIV-1 DNA Quantitation in Blood Cells for Early Diagnosis in Infants Born to Seropositive Mothers Treated in HAART Area ( ANRS CO 01 ) , 2008 .
[42] C. Rouzioux,et al. HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors , 2008, AIDS.
[43] Todd M. Allen,et al. Genetic Characterization of Human Immunodeficiency Virus Type 1 in Elite Controllers: Lack of Gross Genetic Defects or Common Amino Acid Changes , 2008, Journal of Virology.
[44] Terri Wrin,et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. , 2008, The Journal of infectious diseases.
[45] Tina Lenasi,et al. HMBA Releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and Activates HIV Transcription , 2007, PLoS pathogens.
[46] M. Peeters,et al. Impact of HIV-1 Genetic Diversity on Plasma HIV-1 RNA Quantification: Usefulness of the Agence Nationale de Recherches sur le SIDA Second-Generation Long Terminal Repeat-Based Real-Time Reverse Transcriptase Polymerase Chain Reaction Test , 2007, Journal of acquired immune deficiency syndromes.
[47] C. Rouzioux,et al. Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study) , 2007, AIDS.
[48] Asier Sáez-Cirión,et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype , 2007, Proceedings of the National Academy of Sciences.
[49] E. Rosenberg,et al. Fully Differentiated HIV-1 Specific CD8+ T Effector Cells Are More Frequently Detectable in Controlled than in Progressive HIV-1 Infection , 2007, PloS one.
[50] R. Siliciano,et al. Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors , 2006, Journal of Virology.
[51] Mario Roederer,et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.
[52] P. Morlat,et al. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[53] C. Rouzioux,et al. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. , 2005, The Journal of infectious diseases.
[54] W. Greene,et al. Prostratin Antagonizes HIV Latency by Activating NF-κB* , 2004, Journal of Biological Chemistry.
[55] T. Perneger,et al. Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions , 2004, AIDS.
[56] W. Greene,et al. Prostratin antagonizes HIV latency by activating NF-kappaB. , 2004, The Journal of biological chemistry.
[57] K. Shuai,et al. Regulation of JAK–STAT signalling in the immune system , 2003, Nature Reviews Immunology.
[58] C. Hallahan,et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors , 2002, Nature Immunology.
[59] E. Rosenberg,et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[60] F. Marincola,et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.